203 related articles for article (PubMed ID: 9091473)
1. Lichenoid changes in mycosis fungoides.
Guitart J; Peduto M; Caro WA; Roenigk HH
J Am Acad Dermatol; 1997 Mar; 36(3 Pt 1):417-22. PubMed ID: 9091473
[TBL] [Abstract][Full Text] [Related]
2. The histologic spectrum of mycosis fungoides/Sézary syndrome (cutaneous T-cell lymphoma). A review of 222 biopsies, including newly described patterns and the earliest pathologic changes.
Shapiro PE; Pinto FJ
Am J Surg Pathol; 1994 Jul; 18(7):645-67. PubMed ID: 8017560
[TBL] [Abstract][Full Text] [Related]
3. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part I. Diagnosis: clinical and histopathologic features and new molecular and biologic markers.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):205.e1-16; quiz 221-2. PubMed ID: 24438969
[TBL] [Abstract][Full Text] [Related]
4. Persistent pigmented purpuric dermatitis and mycosis fungoides: simulant, precursor, or both? A study by light microscopy and molecular methods.
Toro JR; Sander CA; LeBoit PE
Am J Dermatopathol; 1997 Apr; 19(2):108-18. PubMed ID: 9129694
[TBL] [Abstract][Full Text] [Related]
5. Mycosis fungoides/Sézary syndrome: report of an unusual case.
Mehta A; Dhungel BM; Khan MF
J Cutan Pathol; 2006 Sep; 33 Suppl 2():12-5. PubMed ID: 16972946
[TBL] [Abstract][Full Text] [Related]
6. Palmoplantar hyperkeratosis in mycosis fungoides.
Aram H; Zeidenbaum M
J Am Acad Dermatol; 1985 Nov; 13(5 Pt 2):897-9. PubMed ID: 2933430
[TBL] [Abstract][Full Text] [Related]
7. Mycosis fungoides and Sézary's syndrome show distinct histomorphological features.
Imai S; Burg G; Braun-Falco O
Dermatologica; 1986; 173(3):131-5. PubMed ID: 3770259
[TBL] [Abstract][Full Text] [Related]
8. Cytologic evaluation of lymphadenopathy associated with mycosis fungoides and Sezary syndrome: role of immunophenotypic and molecular ancillary studies.
Pai RK; Mullins FM; Kim YH; Kong CS
Cancer; 2008 Oct; 114(5):323-32. PubMed ID: 18798522
[TBL] [Abstract][Full Text] [Related]
9. Mycosis Fungoides Manifesting as Giant Cell Lichenoid Dermatitis.
Belousova IE; Khairutdinov VR; Bessalova A; Kazakov DV
Am J Dermatopathol; 2018 Apr; 40(4):283-285. PubMed ID: 29135510
[TBL] [Abstract][Full Text] [Related]
10. Long-term outcome of 525 patients with mycosis fungoides and Sezary syndrome: clinical prognostic factors and risk for disease progression.
Kim YH; Liu HL; Mraz-Gernhard S; Varghese A; Hoppe RT
Arch Dermatol; 2003 Jul; 139(7):857-66. PubMed ID: 12873880
[TBL] [Abstract][Full Text] [Related]
11. T-cell receptor gamma gene rearrangement by multiplex polymerase chain reaction/heteroduplex analysis in patients with cutaneous T-cell lymphoma (mycosis fungoides/Sézary syndrome) and benign inflammatory disease: correlation with clinical, histological and immunophenotypical findings.
Ponti R; Quaglino P; Novelli M; Fierro MT; Comessatti A; Peroni A; Bonello L; Bernengo MG
Br J Dermatol; 2005 Sep; 153(3):565-73. PubMed ID: 16120144
[TBL] [Abstract][Full Text] [Related]
12. Scleromyxedematous Changes in a Patient With Long-Standing Mycosis Fungoides Who Progressed to Sézary Syndrome.
Miraflor AP; Pulitzer MP; Myskowski PL; Geller S
Am J Dermatopathol; 2019 Nov; 41(11):e139-e143. PubMed ID: 31169525
[TBL] [Abstract][Full Text] [Related]
13. Primary cutaneous T-cell lymphoma (mycosis fungoides and Sézary syndrome): part II. Prognosis, management, and future directions.
Jawed SI; Myskowski PL; Horwitz S; Moskowitz A; Querfeld C
J Am Acad Dermatol; 2014 Feb; 70(2):223.e1-17; quiz 240-2. PubMed ID: 24438970
[TBL] [Abstract][Full Text] [Related]
14. Histologic criteria for the diagnosis of erythrodermic mycosis fungoides and Sézary syndrome: a critical reappraisal.
Kohler S; Kim YH; Smoller BR
J Cutan Pathol; 1997 May; 24(5):292-7. PubMed ID: 9194582
[TBL] [Abstract][Full Text] [Related]
15. Clinicopathologic and immunologic features associated with transformation of mycosis fungoides to large-cell lymphoma.
Cerroni L; Rieger E; Hödl S; Kerl H
Am J Surg Pathol; 1992 Jun; 16(6):543-52. PubMed ID: 1599034
[TBL] [Abstract][Full Text] [Related]
16. The relevance of peripheral blood T-helper 1 and 2 cytokine pattern in the evaluation of patients with mycosis fungoides and Sézary syndrome.
Papadavid E; Economidou J; Psarra A; Kapsimali V; Mantzana V; Antoniou C; Limas K; Stratigos A; Stavrianeas N; Avgerinou G; Katsambas A
Br J Dermatol; 2003 Apr; 148(4):709-18. PubMed ID: 12752128
[TBL] [Abstract][Full Text] [Related]
17. Basaloid folliculolymphoid hyperplasia: a distinctive finding in follicular mycosis fungoides.
Gerami P; Guitart J
J Cutan Pathol; 2007 Dec; 34 Suppl 1():29-32. PubMed ID: 17997735
[TBL] [Abstract][Full Text] [Related]
18. Lichenoid Granulomatous Mycosis Fungoides.
Garrido MC; Maroñas-Jimenez L; Ortiz PL; Rodriguez-Peralto JL
Am J Dermatopathol; 2017 Aug; 39(8):614-617. PubMed ID: 28654464
[TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of histological and immunohistological features in mycosis fungoides and Sézary syndrome.
Kamarashev J; Burg G; Kempf W; Hess Schmid M; Dummer R
J Cutan Pathol; 1998 Sep; 25(8):407-12. PubMed ID: 9826165
[TBL] [Abstract][Full Text] [Related]
20. Does the new staging system proposed for mycosis fungoides and Sézary syndrome provide reliable agreement for T1 and T2 disease?
Fernández-de-Misa R; Hernández Machín B; Aguirre-Jaime A; Pérez-Méndez LI; Peñate Y; Suárez Hernández J
Dermatology; 2015; 230(1):40-5. PubMed ID: 25471055
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
